Telesis Bio Inc FCF yield
What is the FCF yield of Telesis Bio Inc?
The FCF yield of Telesis Bio Inc is -0.81%
What is the definition of FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield of companies in the Health Care sector on NASDAQ compared to Telesis Bio Inc
What does Telesis Bio Inc do?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Companies with fcf yield similar to Telesis Bio Inc
- Impro Precision Industries Ltd has FCF yield of -0.83%
- Mittal Life Style has FCF yield of -0.82%
- Conversion Labs has FCF yield of -0.82%
- Lattice Biologics has FCF yield of -0.82%
- China HGS Real Estate Inc has FCF yield of -0.82%
- Luduson G has FCF yield of -0.81%
- Telesis Bio Inc has FCF yield of -0.81%
- 10x Genomics has FCF yield of -0.81%
- Albioma has FCF yield of -0.80%
- Medallia Inc has FCF yield of -0.79%
- EnWave has FCF yield of -0.79%
- China Starch has FCF yield of -0.79%
- Pluralsight Inc has FCF yield of -0.79%